Patents by Inventor Alan D. Snow

Alan D. Snow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190350996
    Abstract: Composition and methods for treating brain “plaques” and “tangles” in a patient or an animal wherein the method comprises administration of a therapeutically effective amount of a composition comprising Uncaria tomentosa extract and an oolong tea extract.
    Type: Application
    Filed: June 3, 2019
    Publication date: November 21, 2019
    Applicant: COGNITIVE CLARITY INC.
    Inventors: Judy CAM, Thomas LAKE, Qubai HU, Joel CUMMINGS, Alan D SNOW
  • Publication number: 20190240279
    Abstract: Methods of treating the formation, deposition, accumulation, or persistence of beta-amyloid containing plaques and tau protein containing tangles including the step of treating the plaques or tangles with an effective amount of a composition comprising an Uncaria tomentosa extract and an oolong tea extract Compositions containing an Uncaria tomentosa extract in combination with an oolong tea extract.
    Type: Application
    Filed: August 4, 2017
    Publication date: August 8, 2019
    Applicant: Cognitive Clarity Inc.
    Inventors: Judy Cam, Thomas Lake, Qubai Hu, Joel Cummings, Alan D Snow
  • Patent number: 10350258
    Abstract: Methods of treating the formation, deposition, accumulation, or persistence of beta-amyloid containing plaques and tau protein containing tangles including the step of treating the plaques or tangles with an effective amount of a composition comprising an Uncaria tomentosa extract and an oolong tea extract. Compositions containing an Uncaria tomentosa extract in combination with an oolong tea extract.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: July 16, 2019
    Assignee: Cognitive Clarity Inc.
    Inventors: Judy Cam, Thomas Lake, Qubai Hu, Joel Cummings, Alan D Snow
  • Patent number: 10307454
    Abstract: Composition and methods for treating brain “plaques” and “tangles” in a patient or an animal wherein the method comprises administration of a therapeutically effective amount of a composition comprising Uncaria tomentosa extract and an oolong tea extract.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: June 4, 2019
    Assignee: Cognitive Clarity Inc.
    Inventors: Judy Cam, Thomas Lake, Qubai Hu, Joel Cummings, Alan D. Snow
  • Publication number: 20180002298
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: April 27, 2017
    Publication date: January 4, 2018
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Publication number: 20170333512
    Abstract: Methods of treating the formation, deposition, accumulation, or persistence of beta-amyloid containing plaques and tau protein containing tangles including the step of treating the plaques or tangles with an effective amount of a composition comprising an Uncaria tomentosa extract and an oolong tea extract Compositions containing an Uncaria tomentosa extract in combination with an oolong tea extract.
    Type: Application
    Filed: August 4, 2017
    Publication date: November 23, 2017
    Applicant: Cognitive Clarity Inc.
    Inventors: Judy Cam, Thomas Lake, Qubai Hu, Joel Cummings, Alan D Snow
  • Publication number: 20170022174
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: May 10, 2016
    Publication date: January 26, 2017
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Publication number: 20170008838
    Abstract: This invention relates to the use of bis- and tris-dihydroxyaryl compounds as well as sulfonamides, heteroaryls, tricycloalkyl and their analogs and pharmaceutically acceptable salts, for modulating tau aggregation and alleviating tauopathies, such as Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and familial frontotemporal dementia/Parkinsonism linked to chromosome 17 (FTDP-17), amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: September 14, 2016
    Publication date: January 12, 2017
    Inventors: Alan D. Snow, Qubai Hu, Thomas Lake, Judy Cam
  • Patent number: 9469605
    Abstract: This invention relates to the use of bis- and tris-dihydroxyaryl compounds as well as sulfonamides, heteroaryls, tricycloalkyl and their analogs and pharmaceutically acceptable salts, for modulating tau aggregation and alleviating tauopathies, such as Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and familial frontotemporal dementia/Parkinsonism linked to chromosome 17 (FTDP-17), amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: October 18, 2016
    Assignee: PROTAMED, INC.
    Inventors: Alan D Snow, Qubai Hu, Thomas Lake, Judy Cam
  • Publication number: 20160250273
    Abstract: Composition and methods for treating brain “plaques” and “tangles” in a patient or an animal wherein the method comprises administration of a therapeutically effective amount of a composition comprising Uncaria tomentosa extract and an oolong tea extract.
    Type: Application
    Filed: February 25, 2016
    Publication date: September 1, 2016
    Inventors: Judy Cam, Thomas Lake, Qubai Hu, Joel Cummings, Alan D. Snow
  • Patent number: 9334251
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 10, 2016
    Assignee: PROTAMED, INC.
    Inventors: Luke A Esposito, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D Snow
  • Patent number: 9169255
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of ?-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: October 27, 2015
    Assignee: Proteo Tech Inc.
    Inventors: Luke Esposito, Kelsey Hanson, Marisa C. Yadon, Thomas Lake, Alan D. Snow, Joel Cummings, Anil Kumar
  • Publication number: 20150274681
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: June 16, 2015
    Publication date: October 1, 2015
    Applicant: PROTEOTECH INC.
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Patent number: 9085549
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: July 21, 2015
    Assignee: PROTEOTECH INC
    Inventors: Esposito A Luke, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D. Snow
  • Patent number: 9051253
    Abstract: The use of 3,4,3?,4?-tetrahydroxychalcone in the treatment of amyloid diseases, especially A? amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: June 9, 2015
    Assignee: PROTEOTECH INC.
    Inventors: Alan D. Snow, Beth Nguyen, Gerardo Castillo, Virginia Sanders, Thomas Lake, Lesley Larsen
  • Patent number: 8956818
    Abstract: The identification of novel Syndecan-2 splice variants and their use in the diagnosis and therapeutic intervention of Alzheimer's disease and other amyloid diseases. In addition the use of new animal models expressing or devoid of syndecan-2 splice variants to effectively screen and identify potential therapeutic compounds for Alzheimer's disease.
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: February 17, 2015
    Assignee: ProteoTech Inc.
    Inventors: Alan D. Snow, Qubai Hu, Judy A. Cam, Joel Cummings
  • Publication number: 20150038591
    Abstract: Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of tauopathies, such as Alzheimer's disease and Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Application
    Filed: October 17, 2014
    Publication date: February 5, 2015
    Inventors: Alan D. Snow, Judy A. Cam, Gerardo Castillo, Qubai Hu, Thomas Lake
  • Publication number: 20150011604
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 8, 2015
    Applicant: ProteoTech Inc.
    Inventors: Esposito A Luke, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D. Snow
  • Patent number: 8916598
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: December 23, 2014
    Assignee: Proteotech Inc
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow
  • Patent number: 8895554
    Abstract: Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially A? amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: November 25, 2014
    Assignee: ProteoTech Inc
    Inventors: Alan D. Snow, Beth Nguyen, Gerardo Castillo, Virginia Sanders, Thomas Lake